Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
Clinical trial NCT01923870 · COMPLETED
Trial details
- NCT number
- NCT01923870
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-01-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.